Sign up to save your podcasts
Or
Share Under the microscope: Reporting Season Healthcare Update - Scott Power, Senior Analyst
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Under the microscope: Reporting Season Healthcare Update - Scott Power, Senior Analyst
Morgans Senior Analyst Scott Power shares a Mid-Reporting Season update on the healthcare sector.
Scott discusses 1H results for CSL (CSL), Cochlear (COH), Ansell (ANN), Promedicus (PME), ResMed (RMD) and Virtus Health (VRT).
He also shares his views on Sonic Healthcare (SHL), Mach 7(M7T), Nanosonics (NAN), Volpara Health Technologies (VHT) and Paradigm Biopharma (PAR) who are yet to release their 1H results.
Scott discusses 1H results for CSL (CSL), Cochlear (COH), Ansell (ANN), Promedicus (PME), ResMed (RMD) and Virtus Health (VRT).
He also shares his views on Sonic Healthcare (SHL), Mach 7(M7T), Nanosonics (NAN), Volpara Health Technologies (VHT) and Paradigm Biopharma (PAR) who are yet to release their 1H results.
View all episodes
By Morgans Financial LimitedMorgans Senior Analyst Scott Power shares a Mid-Reporting Season update on the healthcare sector.
Scott discusses 1H results for CSL (CSL), Cochlear (COH), Ansell (ANN), Promedicus (PME), ResMed (RMD) and Virtus Health (VRT).
He also shares his views on Sonic Healthcare (SHL), Mach 7(M7T), Nanosonics (NAN), Volpara Health Technologies (VHT) and Paradigm Biopharma (PAR) who are yet to release their 1H results.
Scott discusses 1H results for CSL (CSL), Cochlear (COH), Ansell (ANN), Promedicus (PME), ResMed (RMD) and Virtus Health (VRT).
He also shares his views on Sonic Healthcare (SHL), Mach 7(M7T), Nanosonics (NAN), Volpara Health Technologies (VHT) and Paradigm Biopharma (PAR) who are yet to release their 1H results.